Report overview
This report contains market size and forecasts of Kidney Cancer in Global, including the following market information:
Global Kidney Cancer Market Revenue, 2018-2023, 2023-2030, ($ millions)
Global top five companies in 2022 (%)
The global Kidney Cancer market was valued at US$ 435.1 million in 2022 and is projected to reach US$ 656.4 million by 2030, at a CAGR of 6.0% during the forecast period 2023-2030.
Global key players of Kidney Cancer include Pfizer, Exelixis, Bristol-Myers Squibb, Novartis, etc. Global top four manufacturers hold a share over 35%. North America has the largest number of Kidney cancer, holds a share of about 50%. In terms of product, targeted therapy is the largest segment, with a share over 45%. And in terms of application, the largest application is renal cell carcinoma, with a share of over 90%.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Kidney Cancer companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Kidney Cancer Market, by Type, 2018-2023, 2023-2030 ($ millions)
Global Kidney Cancer Market Segment Percentages, by Type, 2022 (%)
Surgery
Immunotherapy
Targeted Therapy
Other
Global Kidney Cancer Market, by Application, 2018-2023, 2023-2030 ($ millions)
Global Kidney Cancer Market Segment Percentages, by Application, 2022 (%)
Renal Cell Carcinoma
Renal Pelvis Cancer
Other
Global Kidney Cancer Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions)
Global Kidney Cancer Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Kidney Cancer revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Kidney Cancer revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck
Novartis
Bristol-Myers Squibb
Pfizer
Roche
Amgen
Aveo Pharmaceuticals
Bayer
Exelixis
Eisai
